ALX Oncology
2015
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$23.1M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of protein-based therapeutics intended to help in cancer treatment. The company therapeutics with anticancer antibodies helps immune system to eradicate cancer from the system, enabling physicians to enhance the efficacy of antibody-based therapies in the clinical development.
Website
Formerly Known As
Alexo Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 951 Gateway Boulevard
- Suite 201
- South San Francisco, CA 94080
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ALX Oncology’s full profile, request a free trial.
ALX Oncology Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 01-Jan-2017 | $23.1M | 000.00 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
ALX Oncology Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Lightstone Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Stanford University Venture Fund | Other | Minority | 000 0000 | 000000 0 | ||
| The Longevity Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| venBio | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SPARK Scholars | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
ALX Oncology Executive Team (8)
1 Former Executive
You’re viewing 5 of 8 executives. Get the full list »ALX Oncology Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Corey Goodman | ALX Oncology | Executive Chairman | 000 0000 | |
| Jason Lettmann | Lightstone Ventures | Board Member | 000 0000 | |
| Jaume Pons Ph.D | ALX Oncology | Chief Executive Officer, Board Member, President and Co-Founder | 000 0000 | |
| K. Garcia | ALX Oncology | Board Observer & Board Member | 000 0000 | |
| Laura Deming | The Longevity Fund | Board Observer & Board Member | 000 0000 |